These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
671 related articles for article (PubMed ID: 33298911)
1. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation. Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911 [TBL] [Abstract][Full Text] [Related]
2. TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance. Lin J; Zhang W; Niu LT; Zhu YM; Weng XQ; Sheng Y; Zhu J; Xu J Clin Cancer Res; 2019 Oct; 25(20):6228-6242. PubMed ID: 31235507 [TBL] [Abstract][Full Text] [Related]
3. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence. Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108 [TBL] [Abstract][Full Text] [Related]
4. TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target. Yu JJ; Zhou DD; Yang XX; Cui B; Tan FW; Wang J; Li K; Shang S; Zhang C; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Huang B; Hua F; Hu ZW Nat Commun; 2020 Jul; 11(1):3660. PubMed ID: 32694521 [TBL] [Abstract][Full Text] [Related]
5. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression. Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103 [TBL] [Abstract][Full Text] [Related]
6. TRIB3 destabilizes tumor suppressor PPARα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia. Luo X; Zhong L; Yu L; Xiong L; Dan W; Li J; Ye J; Chu X; Liu C; Liu B Life Sci; 2020 Sep; 257():118021. PubMed ID: 32621919 [TBL] [Abstract][Full Text] [Related]
7. TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability. Xiao MC; Jiang N; Chen LL; Liu F; Liu SQ; Ding CH; Wu SH; Wang KQ; Luo YY; Peng Y; Yan FZ; Zhang X; Qian H; Xie WF J Hepatol; 2024 May; 80(5):778-791. PubMed ID: 38237865 [TBL] [Abstract][Full Text] [Related]
8. TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription. Yu JM; Sun W; Wang ZH; Liang X; Hua F; Li K; Lv XX; Zhang XW; Liu YY; Yu JJ; Liu SS; Shang S; Wang F; Yang ZN; Zhao CX; Hou XY; Li PP; Huang B; Cui B; Hu ZW Nat Commun; 2019 Dec; 10(1):5720. PubMed ID: 31844113 [TBL] [Abstract][Full Text] [Related]
9. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival. Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673 [TBL] [Abstract][Full Text] [Related]
10. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway. Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845 [TBL] [Abstract][Full Text] [Related]
11. Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response. Wennemers M; Bussink J; Scheijen B; Nagtegaal ID; van Laarhoven HW; Raleigh JA; Varia MA; Heuvel JJ; Rouschop KM; Sweep FC; Span PN Breast Cancer Res; 2011 Aug; 13(4):R82. PubMed ID: 21864376 [TBL] [Abstract][Full Text] [Related]
12. TRIB3 confers glioma cell stemness via interacting with β-catenin. Lu Y; Li L; Chen L; Gao Y; Chen X; Cao Y Environ Toxicol; 2020 Jun; 35(6):697-706. PubMed ID: 31995275 [TBL] [Abstract][Full Text] [Related]
13. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection. Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525 [TBL] [Abstract][Full Text] [Related]
14. Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development. Sakai S; Miyajima C; Uchida C; Itoh Y; Hayashi H; Inoue Y Curr Cancer Drug Targets; 2016; 16(2):147-56. PubMed ID: 26560117 [TBL] [Abstract][Full Text] [Related]
15. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor. Örd T; Örd D; Adler P; Vilo J; Örd T Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2492-505. PubMed ID: 26094770 [TBL] [Abstract][Full Text] [Related]
16. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity. Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587 [TBL] [Abstract][Full Text] [Related]
17. Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis. Nguyen HV; Vandenberg CJ; Ng AP; Robati MR; Anstee NS; Rimes J; Hawkins ED; Cory S Blood; 2020 Mar; 135(13):1019-1031. PubMed ID: 31978211 [TBL] [Abstract][Full Text] [Related]
18. FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma. Wang J; Jiang J; Chen H; Wang L; Guo H; Yang L; Xiao D; Qing G; Liu H Oncogene; 2019 Oct; 38(41):6737-6751. PubMed ID: 31406244 [TBL] [Abstract][Full Text] [Related]
19. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation. Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416 [TBL] [Abstract][Full Text] [Related]
20. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1. Xu L; Zhu J; Hu X; Zhu H; Kim HT; LaBaer J; Goldberg A; Yuan J Mol Cell; 2007 Dec; 28(5):914-22. PubMed ID: 18082613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]